TIM
ACAD icon

Thornburg Investment Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Thornburg Investment Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-198,097
Closed -$10.6M – 208
2020
Q4 		$10.6M Buy
+198,097
New +$9.83M 0.13% 135

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Thornburg Investment Management's ACAD Position: Q1 2021 in Review

Thornburg Investment Management sold out of Acadia Pharmaceuticals (ACAD) in Q1 2021, closing a stake of 198,097 shares — an estimated $10.6M sold.

Thornburg Investment Management first reported a position in ACAD in Q4 2020 and held it in 1 quarter. The position peaked at $10.6M in Q4 2020. 272 funds tracked by Wall St. Rank hold ACAD as of Q1 2021.

  • Thornburg Investment Management reported no remaining Acadia Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Thornburg Investment Management sold 198,097 Acadia Pharmaceuticals shares in Q1 2021, an estimated $10.6M.
  • Thornburg Investment Management first reported a position in Acadia Pharmaceuticals in Q4 2020 and held it in 1 quarter.
  • Thornburg Investment Management's Acadia Pharmaceuticals position peaked at $10.6M in Q4 2020.
  • 272 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2021.

Based on Thornburg Investment Management's 13F filing for Q1 2021, filed 14 May 2021.